Skip to Content

UK Edition. Click here for US version.

BELLS CORN & CALLUS OINTMENT

Active substance(s): SALICYLIC ACID

View full screen / Print PDF » Download PDF ⇩
Transcript
SUMMARY OF PRODUCT CHARACTERISTICS

1

NAME OF THE MEDICINAL PRODUCT
BELL’S CORN & CALLUS OINTMENT

2

QUALITATIVE AND QUANTITATIVE COMPOSITION
Salicylic Acid BP 12.5 % w/w

3

PHARMACEUTICAL FORM
OINTMENT

4

CLINICAL PARTICULARS

4.1

Therapeutic indications
A remedy to aid in the removal of corns, callouses and hard skin.

4.2

Posology and method of administration
Adults, Elderly and Children: Apply to the affected small areas of the feet at bedtime.
Cover them if necessary. Wash in warm to hot water in the morning.

4.3

Contraindications

Contraindicated in patients known to be sensitive to Salicylic Acid and also those who
suffer from asthma.
Bell’s Corn & Callus Ointment should not be used by diabetics or patients with
impaired blood circulation. Do not use if the corn or callous or surrounding skin is
inflamed or broken. Do not use on moles, birthmarks, unusual warts with hair growth,
on facial warts, or in the anal or perineal region.

4.4

Special warnings and precautions for use

Bell’s Corn & Callus Ointment is for external use only. Do not permit contact with
eyes or mucous membranes. If contact occurs flush with water for 15 minutes. Do not
allow contact with normal skin around corn or callous. Avoid using on areas of
broken or damaged skin. Discontinue treatment if excessive irritation occurs.
Excessive prolonged use of topical salicylic acid may result in symptoms of
salicylism and must therefore be avoided.
Keep medicines away from children. Wash hands after use.
4.5

Interaction with other medicinal products and other forms of interaction
None.

4.6

Pregnancy and lactation
May be used.

4.7

Effects on ability to drive and use machines
None.

4.8

Undesirable effects
May cause hypersensitivity reactions, skin rashes and dermatitis.
Undesirable effects are listed by MEDRA System Organ Classes.
Assessment of undesirable effects is based on the following frequency groupings:
Very common: ≥1/10
Common:≥1/100 to <1/10
Uncommon:≥1/1000 to <1/100
Rare:≥1/10000 to <1/1000
Very rare:<1/10000
Not known: cannot be estimated from the available data

System Organ Class

Undesirable Effect

Frequency

Skin and subcutaneous
tissue disorders

Skin irritation*

Not known

Injury, poisoning and
procedural complications

Salicylism (including
tinnitus)

Not known

*A localised irritant reaction may occur if Bell’s Corn & Callus Ointment is
applied to normal skin surrounding the corn or callous. This may normally be
controlled by temporarily discontinuing the use of Bell’s Corn & Callus
Ointment and by being careful to apply the solution only to the corn or callous
itself when treatment is resumed.

Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal
product is important. It allows continued monitoring of the benefit/risk balance
of the medicinal product. Healthcare professionals are asked to report any
suspected adverse reactions via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard.
4.9

Overdose

Symptoms of systemic salicylate poisoning have been reported after the application of
salicylic acid to large areas of skin and for prolonged periods. Salicylism may also
occur in the unlikely event of large quantities being ingested. Salicylism is unlikely to
occur if Bell’s Corn & Callus Ointment is used as indicated.

5

PHARMACOLOGICAL PROPERTIES

5.1

Pharmacodynamic properties
Salicylic Acid is keratolytic.

5.2

Pharmacokinetic properties
No information available.

5.3

Preclinical safety data
No information available.

6

PHARMACEUTICAL PARTICULARS

6.1

List of excipients
Maize Starch, Liquid Paraffin, Chlorophyll Oil-Soluble, Yellow Soft Paraffin.

6.2

Incompatibilities
None.

6.3

Shelf life
Three years.

6.4

Special precautions for storage
None.

6.5

Nature and contents of container
Glass jar with wadded hard plastic screwcap: 25 g. Double-wall polyethylene pot
with hard plastic screwcap: 25 g.

6.6

Special precautions for disposal
Not applicable.

7

MARKETING AUTHORISATION HOLDER
Bell Sons and Company (Druggist) Limited
Gifford House
Slaidburn Crescent
Southport
Merseyside
PR9 9AL
United Kingdom

8

MARKETING AUTHORISATION NUMBER(S)
PL 03105/0084

9

DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
29/05/1990

10

DATE OF REVISION OF THE TEXT
08/11/2016

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide